These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7000632)

  • 1. Defective opsonisation and complement deficiency in serum from patients with fulminant hepatic failure.
    Wyke RJ; Rajkovic IA; Eddleston AL; Williams R
    Gut; 1980 Aug; 21(8):643-9. PubMed ID: 7000632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of the serum defect in yeast opsonization in children with fulminant hepatic failure (FHF).
    Larcher VF; Wyke RJ; Mowat AP; Williams R
    Clin Exp Immunol; 1981 Nov; 46(2):406-11. PubMed ID: 7039888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial and fungal infection in children with fulminant hepatic failure: possible role of opsonisation and complement deficiency.
    Larcher VF; Wyke RJ; Mowat AP; Williams R
    Gut; 1982 Dec; 23(12):1037-43. PubMed ID: 6757064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yeast opsonisation and complement in children with liver disease. Analysis of 69 cases.
    Larcher VF; Wyke RJ; Vergani D; Mowat AP; Williams R
    Pediatr Res; 1983 Apr; 17(4):296-300. PubMed ID: 6343990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum stimulatory activity and polymorphonuclear leucocyte movement in patients with fulminant hepatic failure.
    Wyke RJ; Yousif-Kadaru AG; Rajkovic IA; Eddleston AL; Williams R
    Clin Exp Immunol; 1982 Nov; 50(2):442-9. PubMed ID: 7151333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective yeast opsonisation and functional deficiency of complement in sickle cell disease.
    Larcher VF; Wyke RJ; Davis LR; Stroud CE; Williams R
    Arch Dis Child; 1982 May; 57(5):343-6. PubMed ID: 7092289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The classical complement pathway plays a critical role in the opsonisation of uropathogenic Escherichia coli.
    Li K; Sacks SH; Sheerin NS
    Mol Immunol; 2008 Feb; 45(4):954-62. PubMed ID: 17870166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum heat-labile opsonins in systemic lupus erythematosus.
    Jasin HE; Orozco JH; Ziff M
    J Clin Invest; 1974 Feb; 53(2):343-53. PubMed ID: 11344546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired opsonization by serum from patients with chronic liver disease.
    Wyke RJ; Rajkovic IA; Williams R
    Clin Exp Immunol; 1983 Jan; 51(1):91-8. PubMed ID: 6339126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of different K antigens of Escherichia coli in phagocytosis by polymorphonuclear leukocytes.
    Verweij-Van Vught AM; Namavar F; Peerbooms PG; Sparrius M; Maclaren DM
    J Med Microbiol; 1984 Apr; 17(2):141-50. PubMed ID: 6142958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opsonisation and phagocytosis of group B meningococci by polymorphonuclear leucocytes: comparison of sulphonamide sensitive and resistant strains.
    Ward KN; Fleer A; Verhoef J; Jones DM
    J Clin Pathol; 1987 Apr; 40(4):361-7. PubMed ID: 3108325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment by Bacteroides species of opsonisation and phagocytosis of enterobacteria.
    Jones GR; Gemmell CG
    J Med Microbiol; 1982 Aug; 15(3):351-61. PubMed ID: 6126594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preventive long-term intravenous immunoglobulin infusion in children with acute lymphatic leukemia. II. Zymosan opsonization is decreased and is not increased by IgG infusions].
    Nürnberger W; Willers R; Schroten H; Bünning G; Göbel U; Wahn V
    Monatsschr Kinderheilkd; 1988 Apr; 136(4):181-5. PubMed ID: 3164442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opsonic effect of normal and infected human urine on phagocytosis of Escherichia coli and yeasts by neutrophils.
    Suzuki Y; Fukushi Y; Orikasa S; Kumagai K
    J Urol; 1982 Feb; 127(2):356-60. PubMed ID: 7038145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bactericidal, bacteriolytic and opsonic activity of human serum against Escherichia coli.
    Rozenberg-Arska M; Porsius JC; Jaarsma EY; Verhoef J
    J Med Microbiol; 1986 Sep; 22(2):143-9. PubMed ID: 3528498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective yeast opsonisation of serum in sarcoidosis.
    Johnson NM; McNicol MW; Kapoor A; Burton-Kee JE; Mowbray JF
    Thorax; 1980 Apr; 35(4):282-5. PubMed ID: 7001665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opsonic requirements of Helicobacter pylori.
    McKinlay AW; Young A; Russell RI; Gemmell CG
    J Med Microbiol; 1993 Mar; 38(3):209-15. PubMed ID: 8455190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A defect of the alternative pathway of complement.
    Soothill JF; Harvey BA
    Clin Exp Immunol; 1977 Jan; 27(1):30-3. PubMed ID: 321158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yeast opsonisation in children with chronic diarrhoeal states.
    Candy DC; Larcher VF; Tripp JH; Harries JT; Harvey BA; Soothill JF
    Arch Dis Child; 1980 Mar; 55(3):189-93. PubMed ID: 6992714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of C3 levels on yeast opsonization by normal and pathological sera: identification of a complement independent opsonin.
    Kerr MA; Falconer JS; Bashey A; Beck JS
    Clin Exp Immunol; 1983 Dec; 54(3):793-800. PubMed ID: 6652976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.